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E-mail address: higashik2@sc.sumitomo-chem.co.jDermokine-b is abundant in stratiﬁed epithelia and in differentiating cultured keratinocytes. In this
study, we investigated the role of dermokine-b in differentiation of keratinocytes. Treatment of
keratinocytes or skin tumor cells with dermokine-b attenuated phosphorylation of extracellular-
signal-regulated kinase (ERK). Exposure of cells to dermokine-b, as well as its carboxyl-terminus
domain peptide, interrupted phosphorylation of ERK and stimulated dermokine gene expression.
Inhibition of ERK signaling by its speciﬁc inhibitor also increased dermokine expression level. A
combination of chemical cross-linking and immunoprecipitation, followed by proteomics analyses,
identiﬁed glucose-regulated protein 78 (GRP78) as a dermokine-b-associated protein. Blockage of
GRP78 expression by a speciﬁc siRNA abrogated actions of dermokine-b. These ﬁndings provide
novel insights into the physiological signiﬁcance of dermokine-b in the epidermis.
Structured summary of protein interactions:
dermokine-Beta physically interacts with GRP78 by cross-linking study (View interaction)
dermokine-Beta(Glo2) and GRP78 physically interact by competition binding (View interaction)
dermokine-Beta binds to GRP78 by anti bait coimmunoprecipitation (View interaction)
 2012 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
The epidermis is a keratinized, stratiﬁed squamous epithelium
composed of basal, spinous, granular, and corniﬁed cell layers [1].
Keratinocytes differentiate in the basal layer, where epidermal
stem cells are abundant, and migrate gradually to the corniﬁed
layer [2]. Numerous studies of spatial and temporal changes in gene
expression patterns during keratinocyte differentiation have re-
vealed layer-speciﬁcity. Involucrin, transglutaminases, loricrin,
cystatin, ﬁlaggrin and desmoplakin have been identiﬁed as upper
spinous and granular layer-speciﬁc proteins [3].
Dermokine was ﬁrst identiﬁed as a spinous layer-speciﬁc gene
by a signal trap expression screening strategy in mice [4,5]. North-
ern blotting and quantitative RT-PCR revealed that dermokine ischemical Societies. Published by E
kinase; MEK, mitogen-acti-
a; GRP78, glucose-regulated
aka 3-chome, Konohana-ku,
p (K. Higashi).abundant in stratiﬁed epithelia and in differentiating primary hu-
man keratinocytes [4]. Human dermokine has been reported to be
encoded by 25 exons, spanning 17 kb of genomic DNA [4–6]. Its
expression leads to four groups of transcripts according to three dif-
ferent transcriptional start sites, two termination sites and several
alternative coding exons [7]. Unlike the a, b, and c isoforms, dermo-
kine-dmRNAs do not encode a putative signal peptide and are pre-
dicted to produce cytosolic proteins [8]. Although precise
physiological contributions of dermokine have yet to be revealed,
Leclerc et al. demonstrated that dermokine-d activates Rab5 and
thus is involved in early endosomal trafﬁcking [8]. Dermokine-b,
a major isoform in epidermis, does not have signiﬁcant homology
to other proteins. It is generally known that many cytokines, like
bone morphogenetic proteins (BMPs), eotaxin, ﬁbroblast growth
factors (FGFs), interferon-b, interleukins, platelet-derived growth
factor (PDGF), and Wnt proteins (Wnts), have high pI values [4].
The carboxyl terminal domain of dermokine-b also has a high pI va-
lue, suggesting some biological functions of dermokine-b.
Wehave recently shown that the expression levels of dermokine-
bwere increased in inﬂammatory skin disorders, while decreased in
skin cancers [9]. Proinﬂammatory cytokines such as interleukin-1b,lsevier B.V. All rights reserved.
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expression in culturedhumankeratinocytes. In contrast, growth fac-
tors including epidermal growth factor, insulin-like growth factor-I,
keratinocyte growth factor, and transforming growth factor-a sig-
niﬁcantly reduced dermokine expression [9]. The present study
was conducted to reveal the physiological signiﬁcance of dermoki-
ne-b in the epidermis.2. Materials and methods
2.1. Cell cultures and reagents
Normal human epidermal keratinocytes (Kurabo, Osaka, Japan)
were grown in serum-free medium, Humedia KG2 (Kurabo), in 5%
CO2 at 37 C. Human squamous cell carcinoma (SCC) and G-361
melanoma cells were obtained from Health Science Research Re-
sources Bank (Osaka, Japan), and maintained in Dulbecco’s modi-
ﬁed Eagle’s medium supplemented with 10% fetal calf serum.
Bacterial expression plasmids were prepared by ligating the
respective coding sequence into pGEX-6P-1 (GE Healthcare, Buck-
inghamshire, England). A rat anti-human dermokine-b/c mono-
clonal antibody raised against amino-terminus region of
dermokine-b was prepared as previously described [9]. Anti-
extracellular-signal-regulated kinase (ERK)1/2, phospho-ERK1/2
and GRP78 antibodies, and mitogen-activated protein kinase ki-
nase (MEK)1/2 inhibitor U0126 were purchased from Cell Signal-
ing Technology (Danvers, MA). Glutathione sepharose beads and
PreScission protease were purchased from GE healthcare. A
cross-linker, dithio-bis-maleimidoethane (DTME), was obtained
from Thermo Scientiﬁc (Rockford, IL).BA
(kDa)
55
42
34
70
ERK1/2
(min)0
p-ERK1/2
10 30 60
(μg/ml)0 0.3 1 32.2. Transfection of siRNA
The sense strand sequence of the siRNA used for targeting
GRP78 was UGAAGAACUCUUUAACCAGUUGCUG. Stealth RNAi
Negative Control Medium GC Duplex was used as a control (Invit-
rogen, Carlsbad, CA). Normal human keratinocytes were transfec-
ted with 2 lg of siRNA using Lipofectamine 2000 (Invitrogen) as
previously described [10]. Seventy-two hours later, cells were
incubated with recombinant dermokine-b.C
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*2.3. Expression analysis
The amounts of mRNA were quantiﬁed using MESA Blue qPCR
Mastermix (Eurogentec, Seraing, Belgium) as previously described
[9]. Relative mRNA expression levels of each gene were normalized
against those of the glyceraldehyde-3-phosphate dehydrogenase
gene in the same RNA preparation. The primers used were as
follows: dermokine-b/c; forward primer, 50-GGCAATGGAGGGC-
CACCAAAC-30, reverse primer, 50-GGGATTCGTGCACCCTTCATTC-30,
involucrin; forward primer, 50-GGAGCTCCTCAAGACTGTTCCT-30, re-
verse primer, 50-GCTCGACAGGCACCTTCTG-30, GAPDH; forward pri-
mer, 50-AGCGACACCCACTCCTCCAC-30, reverse primer, 50-GAGGTC
CACCACCCTGTTGC-30.Incubation (h)
Fig. 1. Dermokine-b inhibits phosphorylation of ERK1/2 in cultured keratinocytes.
(A) Recombinant human dermokine-b was prepared, and stained with Coomassie
Brilliant Blue. Note that only one band was observed, with molecular weight of
50 kDa. (B) Normal human keratinocytes were treated with dermokine-b for
various periods of incubation at 3 lg/ml (upper panel) or at various concentrations
for 60 min (lower panel). The levels of phosphorylated ERK1/2 and ERK1/2 were
detected in the same Western blot membrane. Similar results were obtained in
three independent experiments. (C) Human keratinocytes were treated with
dermokine-b for various periods of incubation, and the caspase-3/7 activity was
determined. Data shown are mean ± S.D. values (n = 3). ⁄, P < 0.05.2.4. Recombinant protein
The secreted form of dermokine-b, its partial peptides, and
GRP78 fused to glutathione S-transferase (GST) were expressed
in Escherichia coli and puriﬁed as previously described [11].
Through the puriﬁcation on glutathione sepharose beads and Pre-
Scission protease cleavage, recombinant dermokine-b, partial pep-
tides, and GRP78 with high purity were obtained.2.5. Chemical cross-linking, immunoprecipitation, and
microsequencing
Chemical cross-linking reactions were performed as previously
described [12]. Brieﬂy, human keratinocytes cultured in the media
without bovine pituitary extract (BPE) for 3 days were incubated
with 10 lg/ml of dermokine-b for 30 min, and then DTME
(0.2 mM) was added for 30 min at 37 C. After the cross-linking
reaction, cell lysates were prepared and immunoprecipitation
using rat anti-dermokine-b/cmonoclonal antibody was performed
as previously described [11]. Proteins bound to beads were re-
solved by 5–10% SDS–PAGE, and then visualized by silver staining.
Desired bands were excised, in-gel digested with trypsin and sol-
vent extracted, and the resulting MS/MS spectra were searched
using the MASCOT search engine as previously described [13].
2.6. Western blot
Whole cell extracts were resolved by SDS/PAGE, transferred to a
PVDF membrane, and blocked with 5% bovine serum albumin for
30 min at room temperature as previously described [13]. After
incubation with primary antibodies, the proteins of interest on
immunoblots were detected using an enhanced chemilumines-
cence detection system.
2.7. Caspase activity
The apoptotic response was measured by Apo-ONE Homoge-
neous Caspase-3/7 Assay (Promega GmbH, Mannheim, Germany)
in accordance with the instructions of the manufacturer.
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Values are expressed as mean ± S.D. The Student’s t-test was
used to evaluate the statistical signiﬁcance of differences between
groups. A P-value of less than 0.05 was considered signiﬁcant.3. Results
3.1. Dermokine-b inhibits phosphorylation of ERK1/2 in cultured
keratinocytes
Previous studies have shown that dermokine is abundant in
stratiﬁed epithelia and in differentiating cultured keratinocytes
[4,9]. Since the carboxyl-terminal domain of dermokine-b shares
a high pI value with many cytokines, human keratinocytes cul-
tured in growth medium were treated with recombinant dermo-
kine-b (Fig. 1A). We ﬁrst examined the effects of exogenous
dermokine-b on proliferation signaling. As shown in Fig. 1B, expo-
sure of keratinocytes to dermokine-b inhibited phosphorylation of
ERK1/2. However, the phosphorylation levels of Akt were not
changed by dermokine-b (data not shown). As caspases are acti-
vated in the terminal differentiation in keratinocytes [14], intra-
cellular caspases activities by dermokine-b were determined. As
shown in Fig. 1C, treatment of keratinocytes with 3 lg/ml of
dermokine-b for 24 h signiﬁcantly elevated caspase activity,
whereas viable cell number of dermokine-b-treated keratinocytes
was comparable with that of control up to 72 h (data not shown).A
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Fig. 2. Carboxyl-terminus domain of dermokine-b exhibits functional activities. (A)
Expression levels of dermokine and involucrin were determined by real-time RT-PCR. Rel
the same total RNA preparation (mean ± S.D., n = 4). (B) Dermokine-b partial peptides use
was ﬁrst expressed as GST-fused protein, and then cleaved by PreScission protease. The g
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like domain; Spa, spacer domain; Glo2, carboxyl-terminus globular domain. (C) Human k
24 h. Total RNA was extracted, and quantitative analysis of dermokine-b/cmRNA express
normalized to those of GAPDH measured in the same total RNA preparation (mean ± S.D
Glo2 peptide for 1 h. The levels of phosphorylated ERK1/2 and ERK1/2 were determin
independent experiments. Data shown are mean ± S.D. values. ⁄, P < 0.05.3.2. Carboxyl-terminus domain of dermokine-b exhibits functional
activities
We further explored the effects of dermokine-b on cell differen-
tiation of keratinocytes. As shown in Fig. 2A, exposure of keratino-
cytes to dermokine-b for 24 h stimulated its gene expression in a
dose-dependent manner, whereas no signiﬁcant change of involu-
crin expression was observed. A secreted form of dermokine-b con-
sists of amino-terminus globular (Glo1), coiled-coil collagen-like
(Coil), keratin-like (Ker), spacer (Spa) and carboxyl-terminus globu-
lar domain (Glo2) [6]. To deﬁne the active regions of dermokine-b to
stimulate its gene expression, dermokine-b deletion mutants were
prepared, and incubated with keratinocytes at a dose of 3 lg/ml
(Fig. 2B). Interestingly, only the Glo2 peptide markedly enhanced
dermokine-b/c gene expression (Fig. 2C). In addition, the Glo2 pep-
tide signiﬁcantly decreased the phosphorylation level of ERK1/2 in
cultured keratinocytes (Fig. 2D). In contrast, other peptides had no
effects on phosphorylation status of ERK1/2 (data not shown).
3.3. Inhibition of ERK signaling stimulates dermokine-b gene
expression
Next, we addressed the question of whether the blockage of
ERK1/2 phosphorylation leads to the activation of caspase or the
elevation of dermokine-b gene expression. Human keratinocytes
were treatedwithMEK1/2 inhibitor U0126 for 24 h, and the activity
of caspase-3/7 was determined. Consistent with a previous study
[15], exposure of keratinocytes to U0126 signiﬁcantly enhancedB
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K. Higashi et al. / FEBS Letters 586 (2012) 2300–2305 2303caspase activity (Fig. 3A). Under the same conditions, inhibition of
ERK1/2 activity by U0126 increased both dermokine-b/c (Fig. 3B)
and dermokine-a (data not shown) gene expressions. In addition,
the expression level of involucrin was also elevated by U0126 (data
not shown). These results suggested that dermokine-b inhibits
ERK1/2 phosphorylation followed by the increase in caspase activ-
ity and dermokine gene expression.
Our recent study showed that dermokine-b/c expression was
diminished in squamous cell carcinoma (SCC), which is derived
from keratinocytes [9]. In addition, expression of dermokine-b/c
was not observed in non-keratinocyte-derived tumor cells such
as malignant melanoma [9]. These results raised the possibility
that exogenous dermokine-b also impairs ERK signaling in skin
tumor cells. Treatment of SCC cells with U0126 for 1 h totally
blocked ERK1/2 phosphorylation (Fig. 3C). Consistent with the re-
sults shown in Fig. 2D, dermokine-b as well as the Glo2 recombi-
nant peptide suppressed ERK1/2 phosphorylation (Fig. 3C). In a
parallel series of experiments, phosphorylated ERK1/2 levels in
the presence of dermokine-b or the Glo2 peptide in melanoma
cells were also reduced (Fig. 3D). These results demonstrated that
the secreted protein dermokine-b inhibits ERK signaling in cul-
tured keratinocytes and skin tumor cells. Moreover, our results
strongly suggested that carboxyl-terminus domain of dermoki-
ne-b confers its physiological functions.C D
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Fig. 3. Inhibition of ERK signaling stimulates dermokine-b gene expression. (A)
Human keratinocytes were treated with various doses of U0126 for 24 h, and
caspase-3/7 activity was determined. Data shown are mean ± S.D. values (n = 3). (B)
Human keratinocytes were treated with various doses of U0126 for 24 h. Total RNA
was extracted, and quantitative analysis of dermokine-b/c mRNA expression was
performed by real time RT-PCR. Relative expression level of dermokine was
normalized to those of GAPDH measured in the same total RNA preparation
(mean ± S.D., n = 4). (C, D) Human squamous cell carcinoma (C) or G-361 melanoma
cells (D) were treated with 3 lg/ml of dermokine-b, the Glo2 peptide, or 1 lM of
U0126 for 1 h. The levels of phosphorylated ERK1/2 and ERK1/2 were detected in
the same Western blot membrane. Similar results were obtained in three
independent experiments. Data shown are mean ± S.D. values. ⁄⁄, P < 0.01;
⁄, P < 0.05.3.4. Dermokine-b exerts physiological functions through direct binding
to GRP78
The results described above led us to investigate the molecular
mechanism by which dermokine-b inhibits ERK signaling. We ﬁrst
searched for interacting proteins on the cell surface with dermoki-
ne-b. After incubation of keratinocytes with dermokine-b, a chem-
ical crosslinking followed by immunoprecipitation using
dermokine-b/c monoclonal antibody was performed. As shown in
Fig. 4A, a band with molecular mass of 230 kDa was detected by
Western blotting (left) and silver staining (right). The relevant
band was excised, analyzed by mass spectrometry, and identiﬁed
as demokine and GRP78. To conﬁrm the direct binding between
dermokine-b and GRP78, each recombinant protein was mixed
and immunoprecipitation using dermokine-b/c monoclonal anti-
body was performed in the presence or absence of the Glo2 pep-
tide. As shown in Fig. 4B, dermokine-b speciﬁcally bound to
GRP78, and this binding was completely blocked in the presence
of the Glo2 peptide. However, the addition of Glo2 peptide had
no effects on the binding of anti-dermokine-b/c monoclonal anti-
body to dermokine-b (Fig. 4B). These results suggested that dermo-
kine-b exerts its functions through direct binding to GRP78. To
examine this possibility, we employed the RNA interference tech-
nique using GRP78-speciﬁc double-stranded RNA. Transfection of
human keratinocytes with GRP78 siRNA signiﬁcantly eliminated
the expression of GRP78 protein (Fig. 4C). On the other hand,
down-regulation of GRP78 expression did not affect the cell num-
ber or morphology (data not shown). Under the experimental con-
ditions, treatment of cells with GRP78 siRNA restored dermokine-
b-reduced ERK1/2 phosphorylation (Fig. 4D). Moreover, down-reg-
ulation of GRP78 expression signiﬁcantly abrogated dermokine-b-
stimulated dermokine gene expression (Fig. 4E) and caspase activ-
ity (Fig. 4F). Collectively, our results suggested that dermokine-b
exerts its functions through direct binding to GRP78.
4. Discussion
Terminal differentiation of skin keratinocytes is a vertically-di-
rected multistep process that is tightly controlled by the sequential
expression of genes. Several factors have been suggested to play
roles in keratinocyte differentiation, including calcium, vitamin
D, retinoic acid, and TPA [16]. Calcium is a ubiquitous intracellular
messenger that inﬂuences numerous cellular processes, such as
proliferation, development, muscle contraction, and differentia-
tion. It has been demonstrated that calcium gradient exists in the
epidermis, with the highest levels of extracellular calcium present
in the granular layer, resulting in differentiation of this layer [17].
Analysis of calcium-inducible genes in cultured keratinocytes
using cDNA microarray technique determined the precise gene
expression proﬁle that governs keratinocyte differentiation [16].
Dermokine-b is a secreted protein abundant in stratiﬁed epithelia,
and high calcium concentration markedly elevates dermokine
expression [4,9]. Although dermokine-b does not have signiﬁcant
homology to other proteins, its carboxyl-terminal domain shares
a high pI value with many cytokines, suggesting similar functions
[4]. In this study, we have revealed the critical roles of dermoki-
ne-b in keratinocyte differentiation.
The ERK signaling plays a central role in regulating mammalian
cell growth by relaying extracellular signals from ligand-bound cell
surface tyrosine kinase receptors, such as epidermal growth factor
receptor and platelet-derived growth factor receptor, to the nu-
cleus via cascade of speciﬁc phosphorylation events, beginning
with activation of Ras [18]. Phosphorylated ERK1/2 by MEK1/2
forms a dimmer, translocates into the nucleus, and phosphorylates
many substrates, including transcriptional factors [19]. We showed
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expression. These results implied some transcriptional factors that
phosphorylated by ERK1/2 might inhibit dermokine gene expres-
sion. Future studies should focus on identiﬁcation of such tran-
scriptional repressors that bind to the DNA sequence within
dermokine promoter. A previous study has shown that the phos-
phorylated forms of ERKs were present in the basal cell layer, but
totally disappeared in the granular layer of the normal human epi-
dermis [20]. In the present study, we showed that exposure of hu-
man keratinocytes to dermokine-b signiﬁcantly decreased the
phosphorylation level of ERK1/2 by 50% compared to control in
proliferating culture conditions. Since dermokine-b protein expres-
sion was conﬁned to the granular layer [9], other bioactive media-
tors such as calcium or soluble factors are also involved in the
inactivation of ERK signaling.
GRP78 is traditionally regarded as a major ER (endoplasmic
reticulum) chaperone facilitating protein folding and assembly,
protein quality control, and calcium binding, and regulating ER
stress signaling [21]. Comparative proteomics proﬁling of murine
skin has identiﬁed ﬁve molecular chaperons, including GRP78[22]. In human skin, GRP78 was diffusely distributed in cells from
the suprabasal layers to the stratum corneum, but not the basal
layer [23]. In addition, GRP78 localizes in the keratohyalin granules
of the cells in the granular layer of the epidermis, suggesting the
involvement of GRP78 in the processing and compartmentalization
of proteins, including proﬁlaggrin, repetin, and caspase 14 [23].
The results of the present study have suggested that the spatio-
temporal co-distribution of GRP78 and dermokine-b exerts the
physical and functional interactions.
Numerous studies have shown the GRP78 functions in various
subcellular compartments: ER, nucleus, cytoplasm, mitochondria,
cell-surface, and extracellular space. Cell-surface GRP78 forms
complexes with a variety of extracellular ligands (e.g., Kringle 5,
Par-4, and a2-macroglobulin) and cell-surface anchored proteins
(e.g., Cripto and T-cadherin) [21]. The interactions of cell-surface
GRP78 with a2-macroglobulin or Cripto promote cell proliferation
by activating ERK1/2, p38 MAPK, and PI3K, and cell survival
through the Akt and NF-jB signaling cascade [24–26]. In contrast,
Kringle 5 induces apoptosis of proliferating endothelial cells and
tumor cells through binding of surface-expressed GRP78 and
K. Higashi et al. / FEBS Letters 586 (2012) 2300–2305 2305enhancing caspase-7 activity by disruption of the GRP78-procas-
pase complex [27]. A cancer cell-selective proapoptotic protein,
Par-4 binds to cell-surface GRP78, and ampliﬁes the ER stress path-
way to induce FADD/caspase-8/caspase-3-dependent apoptosis
[28,29]. As the results of a chemical cross-linking and immunopre-
cipitation followed by proteomics analyses, we have suggested
that dermokine-b interacts with cell-surface GRP78. This interac-
tion was also observed using keratinocytes cultured in the media
with BPE (data not shown). The corresponding band was estimated
as 230 kDa, suggesting three molecules of dermokine-b and one
molecule of GRP78 (Fig. 4A). Since dermokine-c forms multimers
in solution [7], trimers of dermokine-b or with other proteins
might physically associate with GRP78. In addition, the direct bind-
ing of dermokine-b to GRP78 via its carboxyl-terminus globular
domain was demonstrated. Functionally, down-regulation of
GRP78 expression in keratinocytes abrogated both the decrease
of ERK1/2 phosphorylation levels and the increase in dermokine
gene expression as well as caspase activity by dermokine-b
(Fig. 4). Since our results suggested that dermokine-b exerts its
functions through direct binding to GRP78, dermokine-b could be
involved in terminal differentiation of keratinocytes dependent
on GRP78. The physiological signiﬁcance of dermokine-b in the
epidermal differentiation is now under investigation using dermo-
kine-b knockout mice.
Unlike the c and d isoforms, dermokine-a is also a secreted pro-
tein that contains the same carboxyl-terminus globular domain as
dermokine-b [4,6]. We and others have suggested that the expres-
sions of both dermokine-b and -a were coordinately regulated
[4,9], implying the additional involvement of dermokine-a in
keratinocyte differentiation. Consistent with the results of a previ-
ous study [30], treatment of keratinocytes with U0126 signiﬁcantly
stimulated involucrin gene expression (Fig. 3B). However, dermo-
kine-b had no effect on expression level of involucrin, while inhib-
iting ERK signaling. This might be explained by distinct regulatory
pathways through the direct binding of dermokine-b/a to GRP78
contributing to the gene expressions of dermokine and involucrin.
Further studies are necessary to clarify the molecular mechanisms
of dermokine/GRP78 signal transduction.
In summary, we have suggested that dermokine-b attenuated
phosphorylation of ERK1/2 followed by the increase in caspases
activities and dermokine expression through direct binding to
GRP78. Since diminution of ERK signaling and activation of caspases
havebeendemonstrated in keratinocytedifferentiation, calcium-in-
duced dermokine-b expression could be involved in keratinization
of epidermis. Here, we provide novel insight into the physiological
signiﬁcance of dermokine-b in the epidermis.Disclosure statement
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